- Recent Funding
- Investors
- Groupe Pasteur Mutualité
Groupe Pasteur Mutualité portfolio
Groupe Pasteur Mutualité has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is FineHeart's $96.9M Series B+ round in January 2026, which it led, alongside NACO, Groupe Etchart, European Innovation Council Fund and 3 others. That company is in Health and bio.
What Groupe Pasteur Mutualité invests in
- Health and bio · 1 · 100%
How Groupe Pasteur Mutualité invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $96.9M |
Groupe Pasteur Mutualité portfolio companies
FFineHeart$96.9MSeries B+ · Jan 2026
| Company | Round with Groupe Pasteur Mutualité | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $96.9M · lead | $122.43M | Jan 9, 2026 Series B+ |
Most frequent co-investors
EEuropean Innovation Council Fund1 shared round · last Jan 9, 2026
NNACO1 shared round · last Jan 9, 2026
GGroupe Etchart1 shared round · last Jan 9, 2026
IIRDI1 shared round · last Jan 9, 2026
DDoliam1 shared round · last Jan 9, 2026
LLurra Capital AG1 shared round · last Jan 9, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Groupe Pasteur Mutualité. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Groupe Pasteur Mutualité, which is a subset of its real portfolio. API: /api/v1/investors/groupe-pasteur-mutualite (get a free API key). More: the most active VC firms and new venture capital funds.